Werewolf Therapeutics, Inc. · NASDAQ:HOWL
PFM Health Sciences, LP reported a 6.50% stake in Werewolf Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
PFM Health Sciences, LP reported a 6.50% stake in Werewolf Therapeutics, Inc., 2,905,465 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 6.50%
- Shares
- 2,905,465
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| PFM Health Sciences, LP | 6.50% | 2,905,465 |
| PFM Health Sciences GP, LLC | 6.50% | 2,905,465 |
| Partner Asset Management, LLC | 6.50% | 2,905,465 |
| Brian D. Grossman | 6.50% | 2,905,465 |
Source
Related
- Werewolf Therapeutics, Inc.
- PFM Health Sciences, LP
- Werewolf Therapeutics, Inc. shareholders
- Schedule 13G/A · PFM Health Sciences, LP · Aug 14, 2025
- Schedule 13G · Moll Peter · Sep 21, 2026
- Form 4 · Luke Evnin · Jul 8, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jul 2, 2026
- Form 4 · Luke Evnin · Jun 29, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jun 26, 2026